Spotlight on contributory role of host immunogenetic profiling in SARS-CoV-2 infection: Susceptibility, severity, mortality, and vaccine effectiveness

Life Sci. 2023 Sep 1:328:121907. doi: 10.1016/j.lfs.2023.121907. Epub 2023 Jun 30.

Abstract

Background: The SARS-CoV-2 virus has spread continuously worldwide, characterized by various clinical symptoms. The immune system responds to SARS-CoV-2 infection by producing Abs and secreting cytokines. Recently, numerous studies have highlighted that immunogenetic factors perform a putative role in COVID-19 pathogenesis and implicate vaccination effectiveness.

Aim: This review summarizes the relevant articles and evaluates the significance of mutation and polymorphism in immune-related genes regarding susceptibility, severity, mortality, and vaccination effectiveness of COVID-19. Furthermore, the correlation between host immunogenetic and SARS-CoV-2 reinfection is discussed.

Method: A comprehensive search was conducted to identify relevant articles using five databases until January 2023, which resulted in 105 total articles.

Key findings: Taken to gather this review summarized that: (a) there is a plausible correlation between immune-related genes and COVID-19 outcomes, (b) the HLAs, cytokines, chemokines, and other immune-related genes expression profiles can be a prognostic factor in COVID-19-infected patients, and (c) polymorphisms in immune-related genes have been associated with the effectiveness of vaccination.

Significance: Regarding the importance of mutation and polymorphisms in immune-related genes in COVID-19 outcomes, modulating candidate genes is expected to help clinical decisions, patient outcomes management, and innovative therapeutic approach development. In addition, the manipulation of host immunogenetics is hypothesized to induce more robust cellular and humoral immune responses, effectively increase the efficacy of vaccines, and subsequently reduce the incidence rates of reinfection-associated COVID-19.

Keywords: COVID-19 susceptibility and outcome; Host immunogenetic diversity; Immunopathology; Reinfection; SARS-CoV-2; Vaccine.

Publication types

  • Review

MeSH terms

  • COVID-19* / genetics
  • Cytokines / genetics
  • Humans
  • Immunogenetics
  • Reinfection
  • SARS-CoV-2
  • Vaccine Efficacy

Substances

  • Cytokines